
Sign up to save your podcasts
Or


In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703.
By NEJM Group4.7
3131 ratings
In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703.

38,498 Listeners

38,914 Listeners

7,670 Listeners

320 Listeners

125 Listeners

499 Listeners

1,403 Listeners

56 Listeners

3,370 Listeners

1,154 Listeners

89 Listeners

5 Listeners

193 Listeners

366 Listeners

6,065 Listeners

374 Listeners

58 Listeners

65 Listeners